Literature DB >> 33382018

Long non-coding RNA MALAT1 modulate cell migration, proliferation and apoptosis by sponging microRNA-146a to regulate CXCR4 expression in acute myeloid leukemia.

Xian-Fu Sheng1, Li-Li Hong1, Hui Li1, Fei-Yan Huang1, Qiang Wen2, Hai-Feng Zhuang1.   

Abstract

OBJECTIVES: To investigate the role of Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) in acute myeloid leukemia (AML) and analyze the potential regulatory network of MALAT1/miR-146a/ CXCR4.
METHODS: The expressions of MALAT1, miR-146a and CXCR4 were performed by qRT-PCR and Western Blot. We conducted trans-well assay, CCK-8 assay and flow cytometry to evaluate the migration, proliferation and apoptosis of AML cells. Also by using luciferase reporter assay, we investigated the interaction between miR-146a and MALAT1 or CXCR4.
RESULTS: Firstly, MALAT1 and CXCR4 were upregulated while miR-146a was downregulated in AML patients compared with healthy controls. We observed a negative correlation between miR-146a and MALAT1 or CXCR4, but a positive correlation between MALAT1 and CXCR4 in AML patients. MALAT1 knockdown inhibited migration and proliferation but induced apoptosis of HL-60 cells. MALAT1 restrained miR-146a expression by acting as a ceRNA. miR-146a regulated HL-60 cells migration, proliferation and apoptosis by directly targeting CXCR4 expression. Finally, we found that CXCR4 expression was downregulated by MALAT1 knockdown and partially restored by miR-146a abrogation.
CONCLUSIONS: Our results showed that MALAT1 regulates migration, proliferation and apoptosis by sponging miR-146a to regulate CXCR4 expression in AML cells, providing novel insights into the role of MALAT1 as a therapeutic target in AML.

Entities:  

Keywords:  Acute myeloid leukemia; CXCR4; HL-60 cells; MALAT1; competing endogenous RNAs; lncRNAs; miR-146a; regulate

Mesh:

Substances:

Year:  2021        PMID: 33382018     DOI: 10.1080/16078454.2020.1867781

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  5 in total

1.  Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis.

Authors:  Ting-Ting Liu; Rui Li; Chen Huo; Jian-Ping Li; Jie Yao; Xiu-Li Ji; Yi-Qing Qu
Journal:  Front Cell Dev Biol       Date:  2021-07-30

Review 2.  Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers.

Authors:  Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Pellegrino Musto; Francesco Albano
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

3.  ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort.

Authors:  Mara Fernandes; Herlander Marques; Ana Luísa Teixeira; Rui Medeiros
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

4.  Nonalcoholic Fatty Liver Hepatocyte-Derived lncRNA MALAT1 Aggravates Pancreatic Cell Inflammation via the Inhibition of Autophagy by Upregulating YAP.

Authors:  Di Liu; Weijie Yao; Kejun Liu; Genwang Wang; Bendong Chen; Zuozheng Wang; Shaozhang Hou
Journal:  Comput Intell Neurosci       Date:  2022-08-31

5.  lncRNA MALAT1 participates in metformin inhibiting the proliferation of breast cancer cell.

Authors:  Yongye Huang; Ziyan Zhou; Jin Zhang; Zhenzhen Hao; Yunhao He; Zihan Wu; Yiquan Song; Kexun Yuan; Shanyu Zheng; Qi Zhao; Tianye Li; Bing Wang
Journal:  J Cell Mol Med       Date:  2021-06-24       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.